Ikaros is the founding member of a small family of C2H2 zinc-finger DNA-binding proteins that carry out critical functions during lymphocyte development. Although interactions between Ikaros and various proteins have been reported, Ikaros-containing complexes have not been purified to determine their composition and identify the predominant interacting partners. In this study, a tandem affinity purification-mass spectrometry strategy was developed for the isolation of complexes formed by Ikaros and by Helios, a T-cell-restricted member of the Ikaros family that remains largely uncharacterized. This strategy, which appears to be well suited for general use in mammalian cells, relies on an N-terminal polypeptide containing a double FLAG epitope, followed by a tobacco etch virus protease cleavage site and calmodulin binding peptide. In extracts from a murine thymocyte line, Ikaros and Helios associated under moderate stringency conditions only with other members of the Ikaros family. However, under low stringency conditions, both tagged proteins assembled into higher molecular weight complexes. Mass spectrometry revealed that both proteins associated predominantly with subunits of NuRD, an ATPdependent nucleosome remodeling complex implicated in transcriptional repression and activation and previously reported to associate with Ikaros. Further analysis of the affinity-purified Ikaros revealed that several serines and threonines are phosphorylated in the thymocyte line, with apparent changes upon thymocyte maturation. These results support the hypothesis that the NuRD complex makes major contributions to the functions of both Ikaros and Helios and that the activities of these proteins may be regulated in part by changes in phosphorylation.
Hematopoietic stem cells give rise to most blood-cell lineages through a developmental program regulated by numerous extracellular signals and transcriptional regulators whose precise functions are rapidly being elucidated. The sequencespecific DNA-binding protein Ikaros is one of the critical regulators of many different stages of hematopoiesis (1) . In addition, mutations in the gene encoding Ikaros can contribute to leukemogenesis and lymphomagenesis, usually in combination with activating mutations of Notch1 (2) .
Ikaros is the founding member of a family of five proteins that exhibit homology within two distinct zinc finger domains. Near its N terminus, full-length Ikaros contains four C2H2 zinc fingers that are responsible for sequencespecific DNA binding. At the C terminus, two additional C2H2 fingers support homodimerization, heterodimerization with other family members, and multimerization (3, 4) . Alternative splicing leads to the production of smaller isoforms of Ikaros, most of which lack portions of the DNAbinding zinc-finger domain (5, 6) . Three of the Ikaros family members, Ikaros, Aiolos, and Helios, are expressed primarily in hematopoietic cells, whereas the other two members, Eos and Pegasus, are expressed more broadly (7, 8) . Ikaros and Aiolos are expressed in most hematopoietic cells, whereas Helios is expressed primarily in T-lineage cells and early multipotential precursors (7, 9) .
Although Ikaros proteins are sequence-specific DNA-binding proteins, and mice lacking Ikaros and Aiolos have been extensively studied (8) , the intracellular functions of proteins within this family have not been clearly established. Mechanistic insights have emerged from four different directions. First, studies of the subnuclear localization of Ikaros revealed that, in interphase cells, Ikaros proteins localize primarily to foci of pericentromeric heterochromatin (10) . Because silent genes co-localize with Ikaros at these foci, it has been hypothesized that Ikaros proteins may regulate gene silencing and perhaps contribute to the recruitment of silent genes to the pericentromeric foci (10) .
Second, studies of potential Ikaros target genes have suggested roles in both repression and activation. Mutations in Ikaros binding sites in the Dntt and Igll1 (5) promoters in stable transfection and transgenic mouse experiments have suggested important roles in transcriptional repression during lymphocyte development (11, 12) . In contrast, an analysis of Cd8a expression in Ikaros-null mice suggested a role in gene activation, with additional support for this hypothesis provided by chromatin immunoprecipitation experiments (13) .
Additional mechanistic insights have emerged from the identification of proteins that associate with Ikaros. In yeast two-hybrid screens, Ikaros associated with Mi-2␣, a catalytic subunit of the NuRD ATP-dependent nucleosome remodeling complex (14) . The Ikaros-NuRD interaction was validated by co-fractionation and co-immunoprecipitation experiments. Ikaros also co-fractionated and co-immunoprecipitated with BRG1, 2 a catalytic subunit of the SWI/SNF nucleosome remodeling complexes (14) , and interactions between Ikaros and two corepressors, Sin3 (15) and the C-terminal binding protein, CtBP (16) , have been observed. However, unlike the IkarosNuRD and Ikaros-BRG1 interactions, the Ikaros-Sin3 and Ikaros-CtBP interactions were confirmed primarily by overexpression of Ikaros or the co-repressor.
The fourth approach used to obtain mechanistic insight has been to study post-translational modifications of Ikaros. Because Ikaros is abundantly expressed throughout hematopoiesis, it has been hypothesized that post-translational modifications may regulate its functions. Indeed, specific phosphorylation events have been found to inactivate Ikaros during the G 2 -M transition (17) and regulate its functions during the G 1 -S transition (18) . Sumoylation has also been reported to regulate the functions of Ikaros (19) .
Despite the progress described above, the mechanisms by which Ikaros contributes to development and oncogenesis remain poorly understood. At the biochemical level, one major deficiency is that multiprotein complexes formed by Ikaros have not been purified and characterized. Purification of Ikaros complexes is necessary to gain insight into the relative importance of the interacting proteins that have been described, and to determine whether additional interacting proteins were missed in previous studies. To this end, we developed a novel tandem affinity purification (TAP) strategy for the purification of both Ikaros and Helios complexes. This strategy was necessary because Ikaros and Helios do not form complexes with other proteins of sufficient stability to survive high stringency washes, necessitating the development of a low stringency purification strategy. The TAP strategy that was developed may be broadly useful for tandem affinity purification in mammalian cells, especially when low stringency conditions are required. The results obtained provide strong support for the hypothesis that the NuRD complex is the predominant interaction partner of both Ikaros and Helios. With the availability of highly purified Ikaros, we were also in a position to use mass spectrometry to identify sites of phosphorylation, revealing a number of Ikaros phosphoacceptors that may help regulate its functions during hematopoiesis and oncogenesis.
EXPERIMENTAL PROCEDURES
Cells, Plasmids, and Retroviruses-The double positive (CD4 ϩ CD8 ϩ ) thymocyte line, VL3-3M2 (20) , was maintained in RPMI medium supplemented with 10% fetal calf serum, antibiotics, and 55 M ␤-mercaptoethanol. Stimulation was carried out with PMA and ionomycin as described previously (21) . Human embryonic kidney 293T cells and mouse fibroblast 3T3 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and antibiotics. Oligonucleotides encoding the tobacco etch virus (TEV) protease site and calmodulin binding peptide were annealed and cloned into pcDNA3 (Invitrogen) containing sequences encoding two adjacent FLAG epitope tags. Helios, Ikaros, HP1␣, HP1␤, and HP1␥ cDNAs were cloned in-frame and downstream of the tag. Hence, the tag is at the N terminus of the expressed protein.
The entire FLAG-TEV-CBP-cDNA (FTC-cDNA) construct was inserted into the pMSCV-IRES-pac retroviral vector. Retrovirus was prepared by transient transfection of HEK 293T cells as described (22) . Helper viruses used for infecting VL3-3M2 cells and 3T3 cells were pCL10A1 and pCLEco, respectively (11, 22) . Stable lines were generated in VL3-3M2 cells by spin infection. 2 ϫ 10 5 cells in log phase were infected with 1 ml of retroviral supernatant by centrifugation for 1 h at 2500 rpm in a tabletop centrifuge at 30°C. After the viral supernatant was removed, the cells were resuspended in RPMI with supplements and aliquoted into a 96-well plate. After 1 day, cells were selected in 1 g/ml puromycin until single colonies were observed.
Nuclear Extract Preparation and Gel Filtration Chromatography-Nuclear extracts were prepared by osmotic swelling and Dounce homogenization as described (23) . Nuclear extraction in the presence of DNase I was carried out as described (24) . Dialysis was carried out in dialysis cassettes (Pierce) with a 3500 molecular weight cutoff for a total of 12 h with two buffer exchanges, into Buffer D (20 mM Hepes, pH 7.9, 1 mM EDTA, 20% glycerol, 1.5 mM MgCl 2 ) at 0.15 M KCl supplemented with protease inhibitors (Roche Applied Science, Complete EDTA free), in a volume 100 times that of the sample at 4°C. Gel filtration was carried out in a prepacked Superose 6 column as described (9) with the following changes: The input volume was 200 l (protein concentration, ϳ4 g/l), and the column was equilibrated with Buffer D at the indicated concentration of KCl or with TEV digestion buffer (50 mM Tris-EDTA, pH 8.0, 150 mM NaCl). In some experiments, fractions were concentrated with 20% trichloroacetic acid (Fisher).
TAP and Mass Spectrometry-40 mg of nuclear extract supplemented with protease inhibitors (Roche Applied Science) and, where required, phosphatase inhibitors (Sigma), in a 10-ml volume, were incubated with 200 l of FLAG-M2-agarose beads (Sigma, 50% slurry) that had been equilibrated in nuclear extract buffer. After incubation for 2 h at 4°C, the beads were pelleted at 700 rpm in a table top centrifuge for 5 min. Beads were washed two times for 5 min each at 4°C with 10 ml of nuclear extract buffer. Beads were then washed twice (1 ml each) with TEV digestion buffer, transferred to a microcentrifuge tube, and resuspended in 1 ml of TEV digestion buffer supplemented with 100 units of TEV protease (Invitrogen). Digestion was carried out for 2 h at room temperature. Beads were pelleted and the supernatant was transferred to a microcentrifuge tube containing pre-equilibrated calmodulin beads and supplemented with 2 mM CaCl 2 , 1 mM imidazole, and 1 mM MgOAc. After overnight incubation at 4°C, beads were pelleted and washed four times in calmodulin binding buffer (25) (9), and Mi-2␤ (26) antibodies have been described previously. Polyclonal antisera were generated against GST-HP1␣ in our laboratory. CtBP (07-306) and p66 (07-365) antibodies were purchased from Upstate Biotechnology; MTA1 (sc10813) and TIF1␤ (sc 19168) antibodies were from Santa Cruz Biotechnology, the RbAp48 (ab 3536) antibody was from Abcam, and the Reptin (612482) antibody was from BD Transduction Laboratories. Secondary antibodies were purchased from Jackson Laboratories. To confirm protein-protein interactions by immunoblot, the inputs and flow-through fractions from each column were incubated in primary antibody at 1:500 dilution overnight in 5% milk. The lanes containing the eluates were excised after transfer and incubated in primary antibody at 1:50 dilution.
Confocal Microscopy-Immunostaining was carried out as described previously (22) , except that 4% paraformaldehyde in phosphate-buffered saline was used for fixation and 0.1% Triton X-100 was used for permeabilization.
RESULTS

Ikaros and Helios Form a Stable Core Complex That Contains
Only Ikaros Family Members-We previously used Ikaros antibodies to purify Ikaros complexes by immunoaffinity chromatography from the RLm11 thymocyte line, which expresses abnormally high concentrations of small Ikaros isoforms (9) . After washing the immunoaffinity columns at high stringency (1 M KCl) and eluting the complexes with high pH, analysis by SDS-PAGE followed by silver-staining revealed the presence of Ikaros isoforms and Helios. However, no other proteins copurified with Ikaros. We reasoned that the absence of co-purifying proteins may be due to 1) the abnormally high abundance of Ikaros in the RLm11 line, 2) the aberrant expression of small Ikaros isoforms, or 3) the use of high stringency wash conditions for purification. The first two possibilities were eliminated when we repeated the procedure using extracts from cell lines that express the largest Ikaros isoforms (i.e. the isoforms that are normally expressed in primary thymocytes) at concentrations comparable to those found in primary thymocytes. 3 Importantly, co-purifying proteins were absent when Ikaros was immunoaffinity purified using antibodies directed against its N terminus, C terminus, or DNA-binding domain, 3 ruling out the possibility that the antibodies disrupted important interactions. Unfortunately, efforts to purify complexes under low stringency conditions when using anti-Ikaros immunoaffinity columns failed because of the high abundance of proteins that associated nonspecifically with Ikaros or with the column resin under low stringency conditions.
To purify Ikaros complexes under reduced stringency conditions, we developed a two-step TAP procedure. The classic TAP tag procedure developed for the purification of multiprotein complexes in yeast makes use of a tag containing protein A followed by a TEV protease cleavage site followed by calmodulin-binding peptide (CBP) (25) . In the classic procedure, a DNA sequence encoding the two tags and the intervening protease cleavage site is fused to the 5Ј-end of the cDNA of interest. The tagged protein and associated proteins are then purified by binding to an immunoglobulin column followed by efficient elution from the column by TEV protease cleavage. Further purification is then achieved by binding to a calmodulin column.
Although the above procedure has been highly successful in yeast, it appears to be less desirable for use in mammalian cells, in part because of the large size of the tag (137, 7, and 26 amino acids for the protein A, TEV protease cleavage site, and CBP site, respectively). For Ikaros in particular, we have found that large tags on either the N terminus or C terminus destabilize the protein (data not shown). For this reason, we developed a modified TAP procedure that makes use of a smaller double FLAG tag in place of protein A.
For this strategy, we prepared a pcDNA3-based expression vector in which a translation initiation codon preceded by a Kozak consensus sequence was used to direct synthesis of a tag containing two FLAG epitopes (double FLAG tag), followed by the TEV protease cleavage site and the 26-residue CBP (Fig.  1A) . Restriction enzyme recognition sequences that can be used for the in-frame insertion of the cDNA of interest follow the CBP-coding sequence. After insertion of the cDNA, the entire coding sequence can be transferred to a murine stem cell virusbased retroviral vector, which includes a puromycin-resistance gene separated from the cDNA of interest by an internal ribosome entry site (IRES) (Fig. 1A) .
Purification of proteins tagged with the double FLAG-TEV-CBP (FTC) peptide relies on serial chromatography of nuclear extracts using first a FLAG immunoaffinity column and then a second calmodulin affinity column. Elution from the anti-FLAG column is performed by cleavage with the TEV protease. As with the conventional TAP tag procedure, elution by TEV protease cleavage offers the advantages of extremely high efficiency elution and mild (low stringency) elution conditions. The resulting eluate is further purified using the calmodulin column, which binds CBP with high affinity in the presence of divalent calcium (Ca 2ϩ ) ions. After binding to the calmodulin column and washing, the final elute is obtained by chelation of the calcium ions with EGTA. Alternatively, prior to SDS-PAGE, the calmodulin beads can be boiled in SDS sample buffer.
A cDNA for mouse Ikaros isoform VI was inserted into the pcDNA3 FTC vector and the FTC-Ikaros cassette was transferred to the retroviral vector. A cDNA for mouse Helios was also inserted because Helios-interacting proteins have not previously been pursued. Clonal lines expressing FTC-Ikaros and FTC-Helios were generated in the mouse VL3-3M2 thymocyte line (20) . This line was chosen because it is representative of CD4ϩCD8ϩ double-positive thymocytes, in terms of general gene expression profile and expression of Ikaros isoforms. Fur-thermore, it has been carefully characterized by Guidos and colleagues (20) and is capable of undergoing early stages of thymocyte-positive selection following T-cell receptor engagement or treatment with PMA and ionomycin.
Immunoblot analysis of several clonal lines revealed that FTC-Ikaros was generally expressed at concentrations comparable to that of endogenous Ikaros ( Fig. 1D and data not shown). FTC-Helios was usually overexpressed relative to endogenous Helios (Fig. 1C ), which we previously had found to be less abundant than endogenous Ikaros (9) . Similar to endogenous Ikaros and Helios, both FTC-Ikaros and FTCHelios were observed at distinct foci in VL3-3M2 nuclei by confocal microscopy (Fig. 1B) . On the basis of previous studies (10), these foci correspond to pericentromeric heterochromatin. Localization to the pericentromeric foci was observed using antibodies against Ikaros, Helios, or the FLAG epitope (Fig. 1B) .
Gel-filtration chromatography of nuclear extracts from the clonal lines revealed that FTC-Ikaros and FTC-Helios co-migrate with their endogenous counterparts, suggesting that they assemble into comparable complexes. In the experiments shown in Fig. 1 (C and D), gel filtration was performed in a buffer containing 0.42 M KCl, which was the same buffer used to elute the proteins from the cell nuclei. Under these conditions, the tagged and endogenous proteins eluted in broad peaks in close proximity to the 669 kDa molecular mass marker, although some variability was observed from experiment to experiment. These results suggest that the tagged proteins and endogenous proteins are incorporated into similar complexes.
To determine the composition of proteins in these complexes, FTCIkaros and FTC-Helios within the 0.42 M KCl extracts were purified by the TAP procedure. In these experiments, the FLAG antibody column was washed with a 0.42 M KCl buffer and the calmodulin column was washed with a 0.15 M NaCl buffer. The immunoblots in Fig. 2A reveal that the tagged proteins bound with high efficiency to the FLAG antibody and calmodulin columns. The reduced size of the proteins (CBPIkaros and CBP-Helios) following elution from the FLAG column using TEV protease is also readily apparent. As a control, extracts from VL3-3M2 cells lacking FTC-tagged proteins were subjected in parallel to the same purification procedure (not shown). Associated proteins were eluted from the calmodulin resin by boiling in SDS sample buffer, which was found to be more efficient than elution in EGTA. Eluates from the anti-FLAG column and calmodulin column were analyzed by SDS-PAGE followed by silver staining (Fig. 2, B and C) . Mass spec- trometry was then used to identify protein bands that were consistently observed in the FTC-Ikaros or FTC-Helios final eluates but not in the control VL3-3M2 eluates.
The results revealed that the FTC-Ikaros and FTC-Helios complexes purified in the presence of 0.42 M KCl contained primarily Ikaros family members (Fig. 2, B and C) . Proteins detected included the CBP-Ikaros and CBP-Helios proteins in their respective samples, endogenous Ikaros isoforms VI and V (the two predominant isoforms expressed in VL3-3M2 cells), Aiolos, and Helios. All other detectable bands (dots in Fig. 2C) were usually observed in the control VL3-3M2 eluates or were not obtained consistently and therefore were considered to be contaminants.
Gel filtration was used to determine whether the purified complexes that contain only Ikaros family members continue to co-migrate with high molecular weight markers. Eluates of the calmodulin column unfortunately could not be analyzed by gel filtration because the use of sample buffer for elution disrupted the complexes. However, an analysis of CBP-Ikaros from the anti-FLAG eluate revealed that the tagged protein and associated endogenous Ikaros migrated between the 442-and 669-kDa markers, suggesting that the complex is only slightly smaller than that observed in the nuclear extracts. Because dimers of Ikaros family members would have molecular masses of only ϳ160 kDa, these results suggest that Ikaros proteins are assembled into multimeric species or, alternatively, exist in an unusual shape. We favor the former hypothesis because of considerable published evidence that Ikaros proteins assemble into multimeric complexes (11, 27) . Nevertheless, the stoichiometry of the multimeric species is difficult to determine from gel filtration data alone.
Ikaros and Helios Re-associate into Larger Complexes following Dialysis-The absence of co-purifying proteins when FTCIkaros and FTC-Helios were purified in a buffer containing 0.42 M KCl suggested that important interactions may be disrupted by this non-physiological salt concentration. Because nonphysiological salt concentrations are generally used to extract DNA-binding proteins from cell nuclei, we asked whether equilibrium dialysis to 0.15 M KCl after nuclear extraction at 0.42 M KCl might allow these proteins to re-assemble into physiological complexes.
After dialysis, Ikaros and Helios both migrated as higher molecular weight complexes when analyzed by gel-filtration chromatography. On the Superose 6 column used for this study, both proteins eluted broadly beginning near the 2-MDa exclusion limit (Fig. 3A) . Although the broad elution profiles of Ikaros and Helios suggested that they may be associated nonspecifically with a variety of proteins in the dialyzed extracts, the complexes that migrated with a particular molecular mass appeared to be stable. That is, when specific fractions were pooled and re-analyzed by gel-filtration chromatography, the Ikaros and Helios proteins eluted in fractions corresponding to the same molecular mass as the original fractions (data not shown). These data suggest that the broad elution profile is not due to transient low affinity interactions that might be expected if the interactions were nonspecific. Nevertheless, it is impossible to determine from these data whether the complexes formed by Ikaros and Helios after dialysis are comparable to the complexes that exist in living cells prior to extract preparation.
To determine the composition of the FTC-Ikaros and FTCHelios complexes in the dialyzed extracts, the complexes were purified using the TAP procedure, with all purification steps performed in the presence of 0.15 M KCl. The high molecular mass complexes were maintained at least through the first column, because FTC-Ikaros and FTC-Helios continued to migrate near the exclusion limit when analyzed by gel filtration (Fig. 3B) . Analysis of the eluates from the calmodulin column by SDS-PAGE followed by silver staining again revealed the pre- 1-3, 1% of the input, flow-through, and eluate, respectively, from the FLAG antibody column were examined. Note the change in size of the tagged protein due to loss of double FLAG tag. In lanes 3-5, 1% of the input and flow-through and 50% of the eluate, respectively, from the calmodulin column were examined. B and C, eluates from the FLAG antibody (B) and calmodulin (C) columns were examined by SDS-PAGE followed by silver staining. TAP experiments were performed using extracts from control VL3-3M2 cells and VL3-3M2 cells stably expressing the FTC-Ikaros and FTC-Helios proteins. Bands marked with circles correspond to proteins that were often observed in the VL3-3M2 control samples and are considered to represent nonspecific interactions. D, after partial purification of FTC-Ikaros on a FLAG antibody column, the eluate was characterized by gel-filtration chromatography followed by immunoblot analysis of column fractions. CBP-Ikaros and endogenous Ikaros continue to migrate as high molecular weight species.
dominant purification of Ikaros family members. However, several additional substoichiometric bands were apparent in the FTC-Ikaros and FTC-Helios eluates that were not apparent in the control VL3-3M2 eluate (Fig. 3C) . As a first step toward determining whether previously identified Ikaros-interacting proteins might be present, an aliquot of the FTC-Ikaros eluate was analyzed by immunoblot using antibodies against Mi-2␤, a catalytic subunit of the NuRD complex. Mi-2␤ was readily detected in the FTC-Ikaros eluate, but not in the control VL3-3M2 eluate (Fig. 3D) . In analogous experiments, Mi-2␤ was not observed in FTC-Ikaros eluates when the TAP procedure was performed at 0.42 M KCl (data not shown). Thus, dialysis to 0.15 M KCl appears to allow Ikaros to re-associate with at least one protein that may be responsible for its biological functions.
Ikaros and Helios Associate Primarily with the NuRD Complex in VL3-3M2 Cells-Although Ikaros and Helios re-associated with other proteins when nuclear extracts prepared with 0.42 M KCl were dialyzed against a buffer containing 0.15 M KCl, we wished to minimize further the possibility that relevant multiprotein complexes might be disrupted during extract preparation in the high salt buffer. We also wanted to avoid the possible re-association of Ikaros and Helios with physiologically irrelevant proteins following extract dialysis. After testing numerous strategies for extraction of Ikaros and Helios from VL3-3M2 nuclei, we found that the proteins could be extracted with reasonable efficiency in a buffer containing 0.25 M KCl and DNase I. DNase I was added to degrade genomic DNA and helped disrupt the binding of Ikaros and Helios to chromatin, although the extraction efficiency was almost as high in the absence of DNase I (data not shown). In extracts prepared using this procedure, FTC-Ikaros and FTC-Helios migrated in a broad peak that began at the void volume of the Superose 6 column (Fig. 4A) , similar to the elution profile observed with the dialyzed extracts. Following the TAP procedure, SDS-PAGE, and SYPRO ruby staining, Ikaros family members and a number of other sub-stoichiometric bands were observed, again similar to the results obtained with the dialyzed extracts (Fig. 4B) . However, fewer background bands were apparent in the VL3-3M2 control eluate than were observed with the dialysis strategy.
To identify the proteins responsible for the sub-stoichiometric bands, each lane of an SDS-PAGE gel containing the FTCIkaros, FTC-Helios, and VL3-3M2 control eluates was cut into 21 slices and tryptic peptides obtained from each slice were analyzed by mass spectrometry. Proteins found within the FTC-Ikaros and FTC-Helios eluates are listed in Table 1 or  supplemental Table S1 . These lists were compiled by first eliminating proteins whose peptides were also found in the VL3- Dialyzed extracts were then examined by gel-filtration chromatography followed by immunoblot analysis using antibodies directed against Helios or Ikaros. The column void volume is 2 MD. B, gel-filtration chromatography was performed after dialyzed FTCHelios-and FTC-Ikaros-containing extracts were partially purified on a FLAG antibody column. C, eluates from the calmodulin column following tandem affinity purification were examined by SDS-PAGE followed by silver staining. TAP was performed with extracts from VL3-3M2 control cells or cells expressing FTC-Helios or FTCIkaros. D, Mi-2␤ was examined after TAP of FTC-Ikaros and control VL3-3M2 extracts by SDS-PAGE followed by immunoblot analysis, using Mi-2␤ antibodies. 0.5% of input and flow-through from the FLAG antibody column (lanes 1 and 2) , 1% of input and flow-through from the calmodulin column (lanes 3 and 4) , and 50% of the final eluate from the calmodulin column (lane 5) were examined.
3M2 control eluate, and by eliminating proteins represented by only one peptide in the mass spectrometry analysis, because at least two unique peptides are often thought to be required for a definitive assignment. 71 proteins were found to be represented by at least two unique peptides in either the FTC-Ikaros or FTC-Helios preparations, and all 71 are shown in either Table 1  or supplemental Table S1 .
Specifically, Table 1 shows proteins and protein complexes that were previously reported to interact with Ikaros, as well as other proteins or protein complexes that may be of interest, based on current knowledge of Ikaros. For a complex to be shown in Table 1 , two unique peptides for at least one subunit had to be detected by mass spectrometry. However, subunits of these complexes that were not represented by two unique peptides in the mass spectrometry profiles are also shown (in parenthesis). We also included in Table 1 the mass spectrometry results obtained for complexes, such as the SWI/SNF and Sin3 complexes, that were previously reported to interact with Ikaros, but were not observed in the mass spectrometry profiles. Once again, parentheses are used to designate subunits that were represented be fewer than two unique peptides. Please note that some proteins, such as HDAC1, HDAC2, RbAp46, and RbAp48, are known to be subunits of multiple complexes and therefore are listed multiple times on Table 1 .
Supplemental Table S1 shows the proteins that are less likely to be of interest, but for which at least two unique peptides were identified in either the FTC-Ikaros or FTC-Helios preparations. Given that the TAP procedure was performed under low stringency conditions, we hypothesize that many of the proteins shown in Table 1 or supplemental Table S1 co-purified with FTC-Ikaros or FTC-Helios because of fortuitous low affinity interactions that have no physiological relevance.
Strikingly, of the 71 proteins for which at least two unique peptides were identified, 11 have been reported to be subunits of the NuRD nucleosome remodeling complex. Furthermore, peptides from 9 of these subunits were found in both the FTCIkaros and FTC-Helios preparations, whereas peptides from only 24 other proteins were detected in both preparations. These results provide strong evidence that the NuRD complex is a primary interaction partner for both Ikaros and Helios in the VL3-3M2 thymocyte line.
It is interesting to note that, although 13 different proteins were identified that have been reported to be components of the NuRD complex, several of these proteins were previously Under these conditions, Ikaros and Helios complexes efficiently elute from the nuclei and migrate as large species with a broad range of molecular weights, as demonstrated here by gel-filtration chromatography with an FTC-Ikaros extract followed by immunoblot analysis of column fractions using Ikaros antibodies. B, FTC-Ikaros and FTC-Helios extracts prepared by nuclear extraction with 0.25 M KCl and DNase I were subjected to tandem affinity purification, followed by SDS-PAGE and SYPRO ruby staining. Untransfected VL3-3M2 extracts were also subjected to tandem affinity purification as a control. Each of the three lanes of the gel was cut into 21 slices. The proteins within each slice were digested with trypsin and analyzed by MS.
TABLE 1 Complexes and proteins identified by mass spectrometry
The numbers of unique tryptic peptides identified by MS in the Ikaros and Helios eluates are shown for each of the proteins below. Proteins for which fewer than two unique peptides were detected are shown in parentheses.
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identified in some NuRD preparations, but not others (28) . This variability raises the possibility that the NuRD complex is heterogeneous and that the broad elution profiles of Ikaros and Helios observed in gel-filtration experiments are due to their interaction with multiple NuRD species. Although the results in Table 1 strongly support the relevance of the Ikaros-NuRD interaction, very few peptides were detected from subunits of three other complexes that have been shown to interact with Ikaros, the BAF, Sin3, and CtBP complexes (other than subunits that are also found in the NuRD complex) (14 -16) . Given that such a large number of peptides from NuRD complex components were detected, the relative absence of peptides from the BAF, Sin3, and CtBP complexes suggests that these complexes were not present in the FTCIkaros and FTC-Helios eluates or were present at substantially lower concentrations (see below). However, we cannot exclude the possibility that the BAF, Sin3, and CtBP complexes associate more efficiently with Ikaros and/or Helios in other cell types or in primary cells. Furthermore, these complexes may associate very weakly with FTC-Ikaros and FTCHelios in VL3-3M2 cells, but dissociate in the buffer conditions used for this analysis.
In addition to the NuRD peptides, reptin, a component of the ␤-catenin complex, Myc complex, and Ino80 complex was enriched in both the Ikaros and Helios complexes (29 -31) . Other proteins identified include components of the clamp loader complex involved in DNA replication (32) , the estrogen receptor ␣ complex (33, 34) , and the Ranbinding protein 9 (RanBPM) complex (35) . Although multiple unique peptides were detected for one or more components of these complexes (Table 1) , we currently have no evidence that these complexes interact with Ikaros or Helios in a biologically significant manner. Finally, we were surprised to find multiple peptides from TIF1␤, a Kruppel-associated box domain containing repressor that associates stoichiometrically with HP1␣ (24) .
To validate the interactions predicted by mass spectrometry, the input, flow-through, and eluate fractions obtained during the TAP procedure were analyzed by immunoblot. Antibodies against four different subunits of the NuRD complex were tested and all four were found in the final eluates (Fig. 5A ). Because only a small fraction of each protein was depleted from the extract during the initial FLAG antibody column, only a small fraction of each of these proteins is associated with Ikaros and Helios under the buffer conditions used for these experiments. Confirmation of the p66 interaction is particularly interesting, as this subunit was found in only one of the previously purified NuRD complexes (28) .
Although NuRD subunits were readily detected by immunoblot, we were unable to confirm the interaction of FTC-Ikaros and FTC-Helios with TIF1␤ or reptin by immunoblot (Fig. 5B) . It is possible that the peptide masses were mis-assigned to TIF1␤ and reptin, but an alternative and perhaps more likely explanation is that the antibodies were unable to detect the proteins present in the purified preparations due to limited sensitivity of the immunoblot experiments. We were also unable to detect either of two subunits of the BAF complex in the final eluates by immunoblot (data not shown), consistent with the absence of BAF complex peptides in the mass spectrometry data. In contrast, although very few CtBP peptides were 15) were analyzed. NuRD components were enriched in eluates from the FTC-Ikaros and FTC-Helios extracts but not from the control VL3-3M2 extracts. B, CtBP, TIF1␤, and reptin were monitored by immunoblot analysis after tandem affinity purification. Samples analyzed were as described above. C, the ability of ectopic HA-Ikaros and HA-Helios to recruit endogenous Mi-2␤ to pericentromeric foci in NIH 3T3 cells was examined by confocal immunofluorescence. The distribution of Mi2-␤ in untransduced cells is shown in panel a. HA antibodies were then used to monitor localization of transduced HA-Ikaros and HA-Helios, with Mi-2␤ antibodies used to monitor Mi-2␤ localization in the same cells (panels b-g).
detected by mass spectrometry, CtBP was detectable by immunoblot in the final eluates. Successful detection of CtBP by immunoblot, with minimal detection of CtBP complex subunits by mass spectrometry, raises the possibility that the CtBP complex did indeed interact with FTC-Ikaros and FTC-Helios in VL3-3M2 cells, but perhaps less efficiently than the NuRD complex.
Helios Can Interact with the NuRD Complex in the Absence of Ikaros-One limitation of the FTC-Helios TAP experiments is that it is difficult to determine whether Helios can interact with the NuRD complex independently of Ikaros, because endogenous Ikaros in VL3-3M2 cells co-purified with FTC-Helios. To determine whether Helios can interact with the NuRD complex in the absence of Ikaros, we used a strategy that was previously employed to validate the interaction between Ikaros and the NuRD complex (36) . Specifically, in NIH 3T3 cells, endogenous Mi-2␤ localizes diffusely throughout the nucleoplasm, but ectopic expression of Ikaros was found to promote the recruitment of Mi-2␤ to foci of pericentromeric heterochromatin (36) .
To determine whether Helios can independently recruit Mi-2␤ to pericentromeric foci, NIH 3T3 cells were transduced with a retrovirus capable of expressing murine Helios with an N-terminal hemagglutinin tag. A retrovirus capable of expressing HA-Ikaros was used as a control. Consistent with previous observations, both HA-Ikaros and HA-Helios localized to foci of pericentromeric heterochromatin (Fig. 5C) . Importantly, both were capable of recruiting endogenous Mi-2␤ to these foci (Fig. 5C) . Similar results were obtained with FTC-Helios (data not shown). Because NIH 3T3 cells do not express Ikaros, the results demonstrate that Helios can interact with the NuRD complex in the absence of Ikaros.
The ability of both Ikaros and Helios to associate independently with the NuRD complex is interesting, because the two family members exhibit little homology outside of their zinc finger domains. Previous overexpression and yeast two-hybrid studies suggested that sequences in close proximity to both the N-and C-terminal zinc finger domains of Ikaros are capable of interacting with the NuRD complex (37) . Our results are consistent with the view that the interaction is mediated primarily by zinc-finger sequences that are homologous between Ikaros and Helios. However, because the N-and C-terminal zinc finger domains are quite different from each other, the functional significance of the NuRD interaction with each of these domains will require further investigation. This will first require the development of a physiologically relevant functional assay for studying the interaction.
HP-1 Proteins and Ikaros Proteins Do Not Stably
InteractIkaros, Helios, and HP1␣ localize with high efficiency to foci of pericentromeric heterochromatin in interphase lymphocytes, leading to the possibility that they might interact with each other. It therefore is noteworthy that we failed to detect peptides from HP1␣, HP1␤, or HP1␥ in our purified FTC-Ikaros and FTC-Helios preparations. However, multiple unique peptides from the HP1-interacting protein TIF1␤ (24) were detected by mass spectrometry, although we were unable to detect TIF1␤ in the final eluates by immunoblot.
To explore in greater depth the possibility that Ikaros and Helios might interact with HP1 proteins, FTC-HP1␣, FTC-HP1␤, and FTC-HP1␥ were stably expressed in VL3-3M2 cells, and complexes containing these proteins were purified using the TAP procedure. The efficiency of binding and elution of the bait protein from both columns was comparable to that observed with FTC-Ikaros and FTC-Helios (Fig. 6A and data   FIGURE 6 . Absence of Ikaros proteins in HP1 protein complexes. A, immunoblot experiments were performed to monitor the efficiency with which FTC-HP1␣ bound and was eluted from the FLAG antibody (FLAG) and calmodulin (CAL) columns in TAP experiments. In lanes 1-3, 1% of the input, flowthrough, and eluate, respectively, from the FLAG antibody column were examined. In lanes 3-5, 1% of the input and flow-through and 50% of the eluate, respectively, from the calmodulin column were examined. B, final eluates from TAP experiments performed with FTC-HP1␣, FTC-HP1␤, and FTC-HP1␥, were analyzed by SDS-PAGE followed by silver staining. Extracts from untransfected VL3-3M2 cells were analyzed as a control. Specific bands were excised and analyzed by mass spectrometry, leading to the band assignments for chromatin assembly factor1 subunits, TIF1␤, and histones, as indicated. not shown). Although numerous proteins have been reported in the literature to interact with HP1 proteins (38) , our purified preparations primarily contained TIF1␤, subunits of the chromatin assembly factor complex (38) and histones (Fig. 6B) . These results support the hypothesis that Ikaros proteins and HP-1 proteins interact independently with pericentromeric heterochromatin.
Phosphorylation of Ikaros in Unstimulated and Stimulated VL3-3M2 Thymocytes-Although Ikaros plays critical roles during multiple stages of hematopoiesis, it is abundantly expressed in all hematopoietic cells, suggesting that its functions may be regulated post-translationally. Indeed, specific phosphorylation events have been found to regulate the activities of Ikaros during the G 2 /M and G 1 /S cell-cycle transitions (17, 18) . Previous studies of Ikaros phosphorylation focused on only a limited number of phosphorylation sites, however, and comprehensive efforts to identify sites of phosphorylation have not been performed.
The development of the TAP strategy made it possible for us to initiate a comprehensive analysis, because we were able to purify sufficient quantities of Ikaros for LC-MS/MS analysis of phosphorylation. We were also able to monitor changes in phosphorylation during cell maturation, as maturation of the VL3-3M2 cell line from a Rag1
lo stage occurs following PMA-ionomycin stimulation (20) .
The TAP procedure was carried out at moderate stringency using nuclear extracts from FTC-Ikaros expressing VL3-3M2 cells, both prior to stimulation and after stimulation with PMA and ionomycin for 5 and 30 min. In the final eluates, CBPIkaros and endogenous Ikaros isoforms VI and V were readily detected (Fig. 7A) . LC-MS/MS with Ikaros isoform VI identified 12 phosphorylation sites (Fig. 7B) . The intensities of the peaks from MS are affected by multiple parameters but can be used as an approximate indicator of abundance of the modification (Fig. 7B) . In addition to the previously described modifications at positions 63 and 168 and in the region 383-404 (17, 18) , many novel and rare sites of phosphorylation were discovered. Phosphorylation at one newly discovered site at position 441 decreased 4-to 5-fold upon PMA/ionomycin stimulation. This site is in close proximity to a recently described multimerization control region that extends from position 444 -451. 4 To test the possible significance of this phosphorylation event, phosphomimetic and alanine substitution mutations were introduced at residue 441 and the mutant Ikaros proteins were subjected to various functional assays. Neither mutation substantially affected functions of Ikaros that can be monitored biochemically or by transient transfection (supplemental Fig.  S1 ). Thus, it will be important in the future to study the roles of the phosphorylation events identified in this analysis in a more physiological context.
DISCUSSION
Ikaros was discovered over 15 years ago (23, 38) and is now known to be a critical regulator of lymphocyte development and tumor formation (39 -41) . However, despite the important biological functions of Ikaros, its mechanisms of action have remained elusive for a variety of reasons. First, consensus DNA recognition sequences for Ikaros have been unusually difficult to define. Ikaros family members are assembled into dimers and multimers in hematopoietic cells, with the dimerization and multimerization domains far removed from the DNA-binding domain (5, 6) . This protein organization allows the subunits of a dimer or multimer to recognize short DNA motifs separated by considerable distances, 5 making it difficult to identify genomic target genes. Second, gene profiling studies with Ikaros-deficient cells have revealed widespread mis-regulation of transcription (42) , further increasing the challenge of identifying direct Ikaros target genes. Third, full-length Ikaros proteins do not generally act as typical activators or repressors of transcription in the types of transfection experiments that are often used to uncover mechanisms of action of transcriptional regulators. Fourth, Ikaros is critical for stages of lymphocyte development that are relatively poorly defined (43) . Finally, multiprotein complexes containing Ikaros family members have not been purified to homogeneity.
Despite these challenges, the identification of Ikaros interacting proteins, including Mi-2␣ and Mi-2␤, Sin3, and CtBP, provided important clues regarding mechanisms of action (14 -16) . However, due to the absence of a functional assay that can be used with confidence to study each interaction, their true biological relevance and relative importance have remained uncertain. The results of the current study provide strong evidence that the NuRD complex is the most prominent partner for Ikaros, as well as for a second member of the Ikaros family, Helios. Because Ikaros and Helios recognize DNA in a sequencespecific manner, the results support the hypothesis that a major function of Ikaros and Helios is to recruit the NuRD complex to specific genomic targets (13) . Critical genomic targets may include genes such as Dntt and Igl1l1 for which Ikaros proteins have been proposed to be critical negative regulators (11, 12) . Ikaros proteins may also recruit the NuRD complex to genes like CD8a, which has been proposed to be an activation target of Ikaros (13) . Furthermore, in cycling cells, Ikaros proteins are located primarily at foci of pericentromeric heterochromatin (14) , raising the possibility that Ikaros recruits the NuRD complex to these broad regions of the genome.
Georgopoulos and colleagues (44) have begun to explore the roles of the NuRD complex in lymphocyte development by conditional disruption of the gene encoding Mi-2␤, the predominant Mi-2 isoform expressed in lymphocytes. Analysis of the mutant mice revealed that Mi-2␤ is a critical regulator of multiple stages of lymphocyte development and is especially important for activation of the Cd4 gene (44) . However, because of the complex phenotypes observed with both Ikaros and Mi-2␤ mutant mice, the critical targets for the Ikaros-NuRD complex have not yet emerged. It is important to add that Helios loss-offunction experiments have not yet been performed.
The Mi-2␣ and Mi-2␤ subunits of the NuRD complex are known to be ATP-dependent nucleosome remodeling proteins and can catalyze nucleosome remodeling in vitro (45, 46) . The presence of histone deacetylases in the complex has led to the suggestion that, despite the nucleosome remodeling activity, NuRD may be primarily involved in transcriptional repression, by catalyzing histone deacetylation at target genes. A number of studies are consistent with a primary role of the NuRD complex in repression (45, 46) . However, at the one critical target of the NuRD complex that was characterized in the Mi-2␤ mutant mice, Cd4, the NuRD complex appears to be essential for gene activation (44) . Thus, additional studies are needed to establish the precise functions of the Ikaros-NuRD complex during lymphocyte development.
Although the MS results suggest that the NuRD complex represents the most prominent partner for both Ikaros and Helios, peptides from another co-repressor previously found to interact with Ikaros in overexpression studies, CtBP (16), were also identified. The CtBP interaction was further confirmed by immunoblot, supporting the hypothesis that this interaction is functionally important. In contrast, peptides were not observed in the MS experiments for unique subunits of either the Sin3 or BAF complexes. Although the results raise the possibility that these previously reported interactions are not functionally important, we cannot rule out the possibility that stable interactions with these complexes occur only in primary cells or in other hematopoietic cell types or stages of differentiation.
Alternatively, the interactions may be functionally important but too weak to survive the low stringency wash conditions. It could be argued that one of the most significant findings to emerge from this analysis is the absence of other proteins that are attractive candidates as important interaction partners for Ikaros and Helios. Peptides for a large number of other proteins were identified, and some of these proteins may indeed carry out relevant interactions with Ikaros and Helios. However, none of these proteins were as abundant as the NuRD subunits in the purified preparations, and none of them stand out as likely candidates for a functional interaction. Therefore, our current working model is that these proteins co-purified with Ikaros and Helios fortuitously and do not carry out functional interactions.
Finally, because of our ability to purify Ikaros to homogeneity under high stringency conditions, we were in a position to examine phosphorylation events by MS. The results revealed a number of phosphorylation events, one of which changes during maturation of the VL3-3M2 thymocyte line. These results may be significant because Ikaros is abundantly expressed throughout lymphocyte development, suggesting that posttranslational modifications may be responsible for regulating its functions. Because mutations in the site that appears to be differentially phosphorylated in unstimulated and stimulated thymocytes had no effect on the properties of Ikaros that can be studied in vitro and in transfection experiments, targeted mutagenesis of this site at the endogenous Ikaros locus may be necessary to evaluate its importance.
To summarize, the TAP-MS strategy described here has allowed us to obtain strong evidence that the NuRD complex is the primary interaction partner for both Ikaros and Helios in immature thymocytes and to identify phosphorylation events that may regulate the functions of Ikaros. These findings will guide future studies of the elusive mechanisms by which Ikaros proteins regulate lymphocyte development and oncogenesis.
